Related references
Note: Only part of the references are listed.YEATS2 is a target of HIF1α and promotes pancreatic cancer cell proliferation and migration
Zhirui Zeng et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
miR-378a-5p inhibits the proliferation of colorectal cancer cells by downregulating CDK1
Kai Li et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2021)
Circular RNA hsa_circ_0033144 (CircBCL11B) regulates oral squamous cell carcinoma progression via the miR-579/LASP1 axis
Wei Zeng et al.
BIOENGINEERED (2021)
MicroRNA-487a-3p inhibits the growth and invasiveness of oral squamous cell carcinoma by targeting PPM1A
Lishan Wang et al.
BIOENGINEERED (2021)
MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2)
Xiang Geng et al.
BIOENGINEERED (2021)
lncRNA GAS5-promoted apoptosis in triple-negative breast cancer by targeting miR-378a-5p/SUFU signaling
Shipeng Zheng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway
Shan Tian et al.
AGING-US (2020)
microRNA-378a-5p iS a novel positive regulator of melanoma progression
Maria Grazia Tupone et al.
ONCOGENESIS (2020)
MiR-378a-5p inhibits angiogenesis of oral squamous cell carcinoma by targeting KLK4
Z. Cui et al.
NEOPLASMA (2020)
Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/beta-Catenin Signaling Pathway and EMT
Jie Wang et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2020)
Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p
Lihua Mu et al.
BIOENGINEERED (2020)
Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics
Sayuri Miyauchi et al.
CLINICAL CANCER RESEARCH (2019)
MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer
Lu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Long-Term Exposure to Oroxylin A Inhibits Metastasis by Suppressing CCL2 in Oral Squamous Cell Carcinoma Cells
Wei-Ting Ku et al.
CANCERS (2019)
Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9
Sha-Sha Wang et al.
MOLECULAR CARCINOGENESIS (2019)
Systems Biology of Cancer Metastasis
Yasir Suhail et al.
CELL SYSTEMS (2019)
MicroRNA replacement therapy in cancer
Homa Mollaei et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma
Shin Pai et al.
CELLS (2019)
Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments
Benjamin Solomon et al.
SEMINARS IN CANCER BIOLOGY (2018)
MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
Rajesha Rupaimoole et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer
Wenyi Mi et al.
NATURE COMMUNICATIONS (2017)
Exclusion of Kaposi Sarcoma From Analysis of Cancer Burden Reply
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2017)
Main components of pomegranate, ellagic acid and luteolin, inhibit metastasis of ovarian cancer by down-regulating MMP2 and MMP9
Huidi Liu et al.
CANCER BIOLOGY & THERAPY (2017)
YEATS2 is a selective histone crotonylation reader
Dan Zhao et al.
CELL RESEARCH (2016)
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
Shanthi Marur et al.
MAYO CLINIC PROCEEDINGS (2016)
Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma
Wei-Fan Chiang et al.
ORAL ONCOLOGY (2013)
Human ATAC Is a GCN5/PCAF-containing Acetylase Complex with a Novel NC2-like Histone Fold Module That Interacts with the TATA-binding Protein
Yuan-Liang Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer
E Lengyel et al.
GYNECOLOGIC ONCOLOGY (2001)